Pharmaceutical technology company XtalPi announced a collaboration with US drug maker Eli Lilly on Tuesday. The partnership will focus on using AI and robotics in drug discovery, with a significant upfront payment of up to $250 million. As part of this collaboration, XtalPi will utilize its ID4Inno™ small-molecule drug discovery platform…
阅读更多（Read More）
XtalPi to collaborate with Eli Lilly on using AI and robotics in drug discovery
作者gocpmall
7 月 14, 2023